BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19528244)

  • 1. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
    Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.
    Rago T; Fiore E; Scutari M; Santini F; Di Coscio G; Romani R; Piaggi P; Ugolini C; Basolo F; Miccoli P; Pinchera A; Vitti P
    Eur J Endocrinol; 2010 Apr; 162(4):763-70. PubMed ID: 20083557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
    Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
    Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
    J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.
    Fiore E; Rago T; Scutari M; Ugolini C; Proietti A; Di Coscio G; Provenzale MA; Berti P; Grasso L; Mariotti S; Pinchera A; Vitti P
    J Endocrinol Invest; 2009 Apr; 32(4):344-51. PubMed ID: 19636204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between serum TSH concentration and thyroid cancer.
    Boelaert K
    Endocr Relat Cancer; 2009 Dec; 16(4):1065-72. PubMed ID: 19620248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
    Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.
    Provenzale MA; Fiore E; Ugolini C; Torregrossa L; Morganti R; Molinaro E; Miccoli P; Basolo F; Vitti P
    Eur J Endocrinol; 2016 Jun; 174(6):813-20. PubMed ID: 27032694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
    Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FNA in the medical management of minimally enlarged thyroid.
    Kini U; Buch A; Bantwal G
    Diagn Cytopathol; 2006 Mar; 34(3):196-200. PubMed ID: 16470863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer.
    Wu X; Lun Y; Jiang H; Gang Q; Xin S; Duan Z; Zhang J
    Endocrine; 2014 Aug; 46(3):554-60. PubMed ID: 24338678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease.
    Fiore E; Vitti P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1134-45. PubMed ID: 22278420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
    Siddiqui MA; Griffith KA; Michael CW; Pu RT
    Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?
    Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW
    Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.